{"nct_id":"NCT05669599","title":"Dose-ranging Study to Evaluate the Efficacy, Safety, and Tolerability of AMG 133 in Adult Subjects With Overweight or Obesity, With or Without Type 2 Diabetes Mellitus","status":"ACTIVE_NOT_RECRUITING","status_verified_date":"2025-02","start_date":"2023-01-18","start_date_type":"ACTUAL","primary_completion_date":"2024-10-08","primary_completion_date_type":"ACTUAL","completion_date":"2026-01-02","completion_date_type":"ESTIMATED","phases":["PHASE2"],"tickers":["AMGN"]}